Skip to main content
logo
Chordia Therapeutics Inc. (TYO:190A)
Japan flag Japan · Delayed Price · Currency is JPY
50.00
0.00 (0.00%)
Oct 27, 2026, 9:14 AM JST

Chordia Therapeutics Ratios and Metrics

Millions JPY. Fiscal year is Sep - Aug.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023
Period Ending
Oct '26 Aug '26 Aug '25 Aug '24 Aug '23
Market Capitalization
3,8685,71712,41851,534-
Market Cap Growth
-53.66%-53.96%-75.90%--
Enterprise Value
1,8163,2119,59648,276-
Last Close Price
50.0074.00180.00780.00-

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023
Period Ending
Oct '26 Aug '26 Aug '25 Aug '24 Aug '23
PB Ratio
2.012.975.1012.38-
P/TBV Ratio
2.012.975.1012.39-

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023
Period Ending
Oct '26 Aug '26 Aug '25 Aug '24 Aug '23
Net Debt / Equity Ratio
-1.07-1.07-1.05-1.04-1.07
Net Debt / EBITDA Ratio
1.401.401.432.41-22.00
Net Debt / FCF Ratio
1.441.441.382.23-8.83
Quick Ratio
10.8710.8710.439.1911.76
Current Ratio
11.1311.1310.929.7811.98
Return on Equity (ROE)
-66.71%-66.71%-54.13%-42.19%-
Return on Assets (ROA)
-38.41%-38.41%-30.59%-23.60%-
Return on Capital Employed (ROCE)
-76.50%-76.50%-73.40%-43.30%4.70%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023
Period Ending
Oct '26 Aug '26 Aug '25 Aug '24 Aug '23
Earnings Yield
-39.48%-25.45%-14.38%-3.55%-
FCF Yield
-36.74%-24.86%-14.84%-3.76%-
Buyback Yield / Dilution
-7.45%-7.45%-16.82%-4.05%-